کاهش علائم صرع در بزرگسالان با عبارت جدید کره ای
ترجمه نشده

کاهش علائم صرع در بزرگسالان با عبارت جدید کره ای

عنوان فارسی مقاله: آیا عبارت کره ای جدید برای صرع علائم بیماری را در بزرگسالان کره ای مبتلا به صرع کاهش می دهد؟
عنوان انگلیسی مقاله: Does the new Korean term for epilepsy reduce the stigma for Korean adults with epilepsy?
مجله/کنفرانس: بیماری صرع و رفتار – Epilepsy & Behavior
رشته های تحصیلی مرتبط: پزشکی
گرایش های تحصیلی مرتبط: مغز و اعصاب
کلمات کلیدی فارسی: بیماری صرع، نام گذاری مجدد بیماری صرع، علائم، افشای تشخیص بیماری صرع، دانش بیماری صرع، افسردگی
کلمات کلیدی انگلیسی: Epilepsy, Renaming epilepsy, Stigma, Disclosure of epilepsy diagnosis, Knowledge about epilepsy, Depression
نوع نگارش مقاله: مقاله پژوهشی (Research Article)
شناسه دیجیتال (DOI): https://doi.org/10.1016/j.yebeh.2019.106719
دانشگاه:  University of Ulsan College of Medicine, Seoul, Republic of Korea
صفحات مقاله انگلیسی: 7
ناشر: الزویر - Elsevier
نوع ارائه مقاله: ژورنال
نوع مقاله: ISI
سال انتشار مقاله: 2020
ایمپکت فاکتور: 2.535 در سال 2019
شاخص H_index: 91 در سال 2020
شاخص SJR: 1.299 در سال 2019
شناسه ISSN: 1525-5050
شاخص Quartile (چارک): Q1 در سال 2019
فرمت مقاله انگلیسی: PDF
وضعیت ترجمه: ترجمه نشده است
قیمت مقاله انگلیسی: رایگان
آیا این مقاله بیس است: خیر
آیا این مقاله مدل مفهومی دارد: ندارد
آیا این مقاله پرسشنامه دارد: ندارد
آیا این مقاله متغیر دارد: دارد
کد محصول: E14188
رفرنس: دارای رفرنس در داخل متن و انتهای مقاله
فهرست مطالب (انگلیسی)

Abstract

1- Introduction

2- Methods

3- Results

4- Discussion

Acknowledgments

References

بخشی از مقاله (انگلیسی)

Abstract

Purpose: The purpose of this study was to evaluate differences in stigma, disclosure management of epilepsy, and knowledge about epilepsy between patients with epilepsy who recognized and did not recognize the new Korean term for epilepsy.

Methods: This was a cross-sectional, multicenter study. The Stigma Scale-Revised, the Disclosure Management Scale, the Patient Health Questionnaire-9, and a questionnaire assessing knowledge about epilepsy were used. The set of questionnaires had two versions, using either the old or new name for epilepsy. Multivariate logistic regression analyses were used.

Results: A total of 341 patients with epilepsy and 509 family members were recruited. Approximately 62% of patients felt some degree of epilepsy-related stigma. Mild stigma, severe concealment of epilepsy diagnosis, and increased knowledge about epilepsy were independently identified as factors associated with recognition of the new term in patients. Recognition of the new term was more prevalent in patients and family members with higher education, female family members, and family members having patients with younger age at seizure onset and shorter duration of epilepsy. There were no significant differences between the two types of questionnaires. About 81% of patients and 93% of family members had a positive attitude about renaming epilepsy.

Conclusion: The use of the new Korean term for epilepsy (cerebroelectric disorder) increased knowledge about epilepsy but did not reduce stigma and concealment of epilepsy diagnosis in Korean adults with epilepsy. Higher education may be an important factor for knowing the new term in patients and family members.

Introduction

Epilepsy is one of the first described neurological diseases and is considered a stigmatizing condition [1]. In spite of the teachings of Hippocrates (460–۳۷۰ BC) that epilepsy is a physical illness, misconceptions regarding the cause of epilepsy became predominant in the Middle Ages [2]. Currently, misconceptions regarding epilepsy have nearly disappeared or are rapidly declining worldwide [3]. However, patients with epilepsy continue to suffer from stigma, as well as social restriction and discrimination, in everyday activities, such as going to school, driving, working, and obtaining insurance [4–۶], not only in the developing world but also in the West [4]. In a large European study, half of patients with epilepsy experienced feelings of stigma associated with epilepsy diagnosis [7]. This perception significantly impacts the quality of life of patients with epilepsy [4,7,8].